Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1373838

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1373838

Global Cell Surface Markers Market Size, Share, Growth Analysis, By Type(Flow cytometers, hematology anlayzers and reagents and kits), By Application(Disease diagnosis and identification and research/drug discovery) - Industry Forecast 2023-2030

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Cell Surface Markers Market size was valued at USD 25.92 billion in 2021 and is poised to grow from USD 27.99 billion in 2022 to USD 51.81 billion by 2030, at a CAGR of 8% during the forecast period (2023-2030).

The global cell surface markers market is a rapidly growing and dynamic industry that plays a crucial role in various fields, including medical research, diagnostics, and drug development. Cell surface markers, also known as cell surface antigens or cluster of differentiation (CD) markers, are proteins or molecules present on the outer surface of cells, which serve as identification tags for specific cell types. These markers are extensively utilized in the identification, isolation, and characterization of different cell populations, aiding in the understanding of cell function, disease mechanisms, and therapeutic targeting. The market is driven by factors such as the increasing prevalence of chronic diseases, rising demand for personalized medicine, advancements in flow cytometry and other cell analysis techniques, and growing investments in research and development activities. Additionally, the expanding applications of cell surface markers in oncology, immunology, stem cell research, and infectious diseases further propel market growth. However, challenges such as the high cost of advanced cell analysis instruments and the complexity of cell surface marker analysis limit the market's full potential. Nevertheless, ongoing technological advancements, such as the development of multiplexed and high-throughput analysis platforms, hold promise for overcoming these barriers and driving the future growth of the global cell surface markers market.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Surface Markers Market Segmental Analysis

Global Cell Surface Markers Market is segmented on the basis of type, application, and region. Based on type, the market can be segmented into Flow cytometers, hematology anlayzers and reagents and kits. Based on application, the market is segmented into Disease diagnosis and identification and research/drug discovery. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Cell Surface Markers Market Dynamics

Drivers for Global Cell Surface Markers Market

Increasing prevalence of chronic diseases

One key driver of the global cell surface markers market is the increasing prevalence of chronic diseases. The rising incidence of chronic diseases, such as cancer, cardiovascular diseases, and autoimmune disorders, drives the demand for cell surface markers. These markers play a crucial role in disease diagnosis, prognosis, and targeted therapies, aiding in personalized medicine approaches. The growing burden of chronic diseases worldwide fuels the demand for advanced cell analysis techniques and drives the overall market growth.

Restraints in the Global Cell Surface Markers Market

High cost of advanced cell analysis instruments and techniques

A key restraint of the global cell surface markers market is the high cost of advanced cell analysis instruments and techniques. The acquisition and maintenance costs associated with sophisticated flow cytometers, hematology analyzers, and other cell analysis platforms can be significant. Additionally, the cost of reagents and kits used in cell surface marker analysis can also be substantial. The high cost of entry and operation limits the accessibility and adoption of advanced cell analysis technologies, especially in resource-constrained settings and emerging markets. This poses a challenge for market growth, particularly in regions where cost-sensitive healthcare systems prevail.

Market Trends of Global Cell Surface Markers Key

Increasing focus on personalized medicine

One key market trend in the global cell surface markers market is the increasing focus on personalized medicine. Personalized medicine aims to tailor medical treatments to individual patients based on their unique characteristics, including cell surface markers. Cell surface markers play a vital role in identifying specific cell populations and determining their response to therapies. The growing understanding of the role of cell surface markers in disease progression and treatment response has led to the development of targeted therapies that can be customized based on an individual's cell surface marker profile. This trend towards personalized medicine is driving the demand for advanced cell analysis techniques and innovative cell surface marker detection methods in the market.

Product Code: SQMIG35J2063

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Cell Surface Markers Market by Type
    • Market Overview
    • Flow cytometers
    • hematology anlayzers and reagents and kits
  • Global Cell Surface Markers Market by Application
    • Market Overview
    • Disease diagnosis and identification and research/drug discovery
  • Global Cell Surface Markers Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • F. Hoffman-La Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • BD (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Grifols SA (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • GenScript (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Siemens Healthcare Private Limited (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Abcam plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Beckman Coulter, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Agilent Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Lonza Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • BioLegend, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Novus Biologicals (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Cell Signaling Technology (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Sino Biological Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • R&D Systems (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!